Timothy A. Springer - Mar 14, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Director, 10%+ Owner
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Stock symbol
RNAC
Transactions as of
Mar 14, 2024
Transactions value $
$666,222
Form type
4
Date filed
3/18/2024, 05:29 PM
Previous filing
Mar 28, 2024
Next filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Purchase $352K +648K +2.17% $0.54 30.5M Mar 14, 2024 See Footnote F1, F2
transaction RNAC Common Stock Purchase $315K +538K +1.76% $0.59 31.1M Mar 15, 2024 See Footnote F2, F3
holding RNAC Common Stock 7.47M Mar 14, 2024 Direct
holding RNAC Common Stock 86.4K Mar 14, 2024 By wife
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.5002 to $0.5600. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
F3 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.5326 to $0.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.